otenabant   Click here for help

GtoPdb Ligand ID: 9232

Synonyms: CP-945,598 | CP-945598
Compound class: Synthetic organic
Comment: Otenabant is a selective cannabinoid CB1 receptor antagonist, which was investigated in clinical trials (as the hydrochloride salt - PubChem CID 16223963) for its potential anorectic action in the treatment of obesity.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 101.44
Molecular weight 509.15
XLogP 4.86
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCNC1(CCN(CC1)c1ncnc2c1nc(n2c1ccc(cc1)Cl)c1ccccc1Cl)C(=O)N
Isomeric SMILES CCNC1(CCN(CC1)c1ncnc2c1nc(n2c1ccc(cc1)Cl)c1ccccc1Cl)C(=O)N
InChI InChI=1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35)
InChI Key UNAZAADNBYXMIV-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Otenabant reached Phase 3 clinical trial, but development was terminated following the withdrawal from the market, of the similar drug rimonabant in 2008, due to it causing serious adverse events (especially nausea and psychiatric disturbances).